3 models fit Coca-Cola Consolidated Inc. Common Stock and they disagree: 1 of 3 land within 15% of the average.
Two or more of our models back this value.
Premium(i)Bronze59
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Dividend discount.
ACCE opinionCoca-Cola Consolidated Inc. Common Stock (COKE)
Fair value (3 models)
$170
ACCE price target
$218
Rating
Overvalued
Horizon
12 months
Fair value published on 19 Oct 2026, 17:05 CEST; previously $159 since 15 Oct 2026, 00:00 CEST.
ACCE price target published on 18 Oct 2026, 00:00 CEST; previously $210 since 21 May 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 17:05 CEST.
Price used: $203 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
19.4% above
-16.2% to fair value
ACCE score
67
out of 100
P/E
27.0x
forward 5.2x
1-year return
+59.2%
Dividend yield
0.47%
Coca-Cola Consolidated Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Coca-Cola Consolidated is the largest Coca-Cola bottler in the United States, producing and distributing Coca-Cola trademark beverages along with brands it bottles under license, sold through its own direct-store-delivery routes. That franchise model, with exclusive territories across much of the eastern US, is the core of the moat: distribution density and shelf access are hard to replicate, and the company carries a 97.3% ROE that reflects a heavily leveraged balance sheet more than pure operating excellence. Revenue growth of 10.6% is running well ahead of what a mature beverage distributor usually delivers, and the 39.1% gross margin shows pricing is sticking. The stock trades at 25.8x trailing earnings but 17.4x forward, so the market is pricing in a meaningful earnings step-up that the next few quarterly prints will either confirm or challenge. It has a 62/100 score and no index membership, which at a $13.6B market cap is worth checking as a possible mispricing, though the 13.2% operating margin and capital intensity of the bottling business mean the earnings path needs verifying before any position is sized.
⚠ Investor warnings · 2 flagsAI-assisted·How I use AI
high
ACCE score collapse
Score fell 11 points in 90 days (73 to 62). Growth and Value both declined to 58-60, signalling deteriorating fundamentals or valuation reset.
high
Massive insider selling
Last 10 disclosures show $3.7B in insider sales, zero buys. No offsetting purchases suggests confidence erosion at management level.
AI research notes
AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-10-09 · prices to Oct 23, 2026
Why it could do well
Revenue accelerated to 10.6% year-over-year growth, well ahead of the 7.6% five-year average, signaling strong pricing power and mix.
The company generated $625M in free cash flow with a 4.8% yield while reducing share count by 7.4%, compounding shareholder value.
Forward P/E of 17.4x sits below the 18.1x sector median despite an exceptional 97.3% return on equity.
Why it could disappoint
Consensus fair value of $163.89 sits 16.5% below the current $196.24 share price, with 3 of 4 valuation models supporting the discount.
Trailing P/E of 26.1x is stretched relative to a forward P/E of 17.4x, implying the market prices in earnings growth the reverse DCF suggests at only 4.5% annually.
The 0.5% dividend yield offers minimal income, and the analyst mean target of $1440.00 appears disconnected from consensus fair value of $163.89.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 4, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where COKE's valuation models land
Price
$203.31
Model fair value
$170
Model range
$119 to $225
Fair value $170
Price $203
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores
+Score history: how each score moved over time
Analysts
Wall Street consensus
No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
+Price-target low / average / high vs the current price, with implied upside
+Forward revenue and EPS consensus by fiscal year
+ACCE fair-value models lined up against the Street
Smart Money
PRO
In one line
Trades are only made public after a delay. We show the delay so you know how old the news is.